Text

A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment

About this Digital Document

Member of
Faculty Publications
Contributor(s)
Author: Difede, JoAnn
Author: McAleavey, Andrew A.
Author: Emrich, Mariel
Author: Jick, Adina
Author: Ovalles, Annell
Author: Wyka, Katarzyna
Author: Spielman, Lisa
Author: Olden, Megan
Author: Peskin, Melissa
Author: Becket-Davenport, Colleen
Author: Rubenstein, Amy
Author: Brownstein, Michael J.
Author: Damiano, Eve
Author: Itzkowitz, Debra
Author: Lu, Shi-fang
Author: Needell, Nancy J.
Author: Kocsis, James H.
Author: Gordon-Elliott, Janna S.
Author: Simon, Neal G.
Publisher
Elsevier BV
Date Issued
2023-06-01
Language
English
Type
Text
Genre
articles
Form
electronic document
Media type
application/pdf
Creator role
Faculty
Identifier
10.1016/j.conctc.2023.101116
2451-8654
Subject (LCSH)
Pharmacology
General Medicine
Related Item
Contemporary Clinical Trials Communications, Volume 33, 2023
Has this item been published elsewhere?
Volume
33
Difede, . J., McAleavey, . A. A., Emrich, . M., Jick, . A., Ovalles, . A., Wyka, . K., Spielman, . L., Olden, . M., Peskin, . M., Becket-Davenport, . C., Rubenstein, . A., Brownstein, . M. J., Damiano, . E., Itzkowitz, . D., Lu, . S.- fang, Needell, . N. J., Kocsis, . J. H., Gordon-Elliott, . J. S., & Simon, . N. G. (2023). (Vols. 33). https://doi.org/10.1016/j.conctc.2023.101116
Difede, JoAnn, Andrew A. McAleavey, Mariel Emrich, Adina Jick, Annell Ovalles, Katarzyna Wyka, Lisa Spielman, et al. 2023. https://doi.org/10.1016/j.conctc.2023.101116.
Difede, JoAnn, et al. 1 June 2023, https://doi.org/10.1016/j.conctc.2023.101116.